000 01482 a2200445 4500
005 20250514023658.0
264 0 _c20020618
008 200206s 0 0 eng d
022 _a0223-5234
024 7 _a10.1016/s0223-5234(01)01293-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWirth, David D
245 0 0 _aIdentification, synthesis and pharmacological activity of moxonidine metabolites.
_h[electronic resource]
260 _bEuropean journal of medicinal chemistry
_cJan 2002
300 _a23-34 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAnimals
650 0 4 _aAntihypertensive Agents
_xchemical synthesis
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aDogs
650 0 4 _aHeart Rate
_xdrug effects
650 0 4 _aHumans
650 0 4 _aImidazoles
_xchemical synthesis
650 0 4 _aMice
650 0 4 _aMice, Inbred Strains
650 0 4 _aOxidation-Reduction
650 0 4 _aRats
650 0 4 _aRats, Inbred F344
650 0 4 _aStructure-Activity Relationship
650 0 4 _aTime Factors
700 1 _aHe, Minxia M
700 1 _aCzeskis, Boris A
700 1 _aZimmerman, Karen M
700 1 _aRoettig, Ulrike
700 1 _aStenzel, Wolfgang
700 1 _aSteinberg, Mitchell I
773 0 _tEuropean journal of medicinal chemistry
_gvol. 37
_gno. 1
_gp. 23-34
856 4 0 _uhttps://doi.org/10.1016/s0223-5234(01)01293-4
_zAvailable from publisher's website
999 _c11750672
_d11750672